Wake EEG oscillation dynamics reflect both sleep need and brain maturation across childhood and adolescence

Snipes, S.; Krugliakova, E.; Jaramillo, V.; Volk, C.; Furrer, M.; Studler, M.; LeBourgeois, M.; Kurth, S.; Jenni, O. G.; Huber, R.

doi:10.1101/2024.02.24.581878

bioRxiv · 10.1101/2024.02.24.581878

Wake EEG oscillation dynamics reflect both sleep need and brain maturation across childhood and adolescence

Snipes, S.·Krugliakova, E.·Jaramillo, V.·Volk, C.·Furrer, M.·Studler, M.·LeBourgeois, M.·Kurth, S.·Jenni, O. G.·Huber, R.

View original source ↗Export metadata ↓

Abstract

1An objective measure of brain maturation is highly insightful for monitoring both typical and atypical development. Slow wave activity, recorded in the sleep electroencephalogram (EEG), reliably indexes age-related changes in sleep pressure as well as deficits related to developmental disorders such as attention-deficit hyperactivity disorder (ADHD). We aimed to determine whether wake EEG measured before and after sleep could index the same developmental changes in sleep pressure, using data collected from 163 participants 3-25 years old. We analyzed ageand sleep-dependent changes in two measures of oscillatory activity, amplitudes and density, as well as two measures of aperiodic activity, offsets and exponents. We then compared these wake measures to sleep slow wave amplitudes and slopes. Finally, we compared wake EEG in children with ADHD (N=58) to neurotypical controls. Of the four wake measures, only oscillation amplitudes consistently exhibited the same changes as sleep slow waves. Wake amplitudes decreased with age, decreased after sleep, and this overnight decrease decreased with age. Furthermore, wake amplitudes were significantly related to both sleep slow wave amplitudes and slopes. Wake oscillation densities decreased overnight in children but increased overnight in adolescents and adults. Aperiodic offsets decreased linearly with age, decreased after sleep, and were significantly related to sleep slow wave amplitudes. Aperiodic exponents also decreased with age, but increased after sleep. No wake measure showed significant effects of ADHD. Overall, our results indicate that wake oscillation amplitudes, and to some extent aperiodic offsets, behave like sleep slow waves across sleep and development. At the same time, overnight changes in oscillation densities independently reflect some yet-unknown shift in neural activity around puberty.

Explore related subjects

neuroscience Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Snipes, S., Krugliakova, E., Jaramillo, V., Volk, C., Furrer, M., Studler, M., LeBourgeois, M., Kurth, S., Jenni, O. G., Huber, R.. 2024-02-28. Wake EEG oscillation dynamics reflect both sleep need and brain maturation across childhood and adolescence. https://doi.org/10.1101/2024.02.24.581878

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗